학술논문

ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study
Document Type
Article
Source
In: Haematologica. (Haematologica, March 2024, 109(3):867-876)
Subject
Language
English
ISSN
15928721
03906078